AccuGel 29:1 is a stabilized, ready-to-use resolution of 40% (w/v) acrylamide : bisacrylamide(29:1). AccuGel 29:1 has zero acrylic acid content material, eliminating the mounted expenses that trigger band streaking. Moreover, oxidation merchandise resembling aldehydes have been eliminated by a selective adsorption course of. With AccuGel 29:1, you possibly can belief that your outcomes shall be constant from one electrophoretic run to the subsequent.
AccuGel 29:1 reduces publicity to neurotoxic acrylamide mud by eliminating the necessity for dealing with and weighing stable acrylamide and methylene bisacrylamide, which regularly results in airborne particulate that may be readily inhaled. In your safety, AccuGel 29:1 is equipped in PVC coated shatter-proof bottles.
Secure and Pure
AccuGel 29:1 is secure for 24 months when saved tightly capped in a darkish space at room temperature. Potential Well being ResultsInhalation
Inhalation of mist causes irritation to the respiratory tract. Signs could parallel ingestion. Ingestion
Poisonous! Might trigger systemic poisoning. Might trigger drowsiness, tingling sensations, fatigue, weak point, stumbling, slurred speech, and shaking. Might trigger central and peripheral nervous system injury. Extreme intoxication could trigger everlasting nerve injury. Might have an effect on reproductive system and act as a teratogen.
Pores and skin
Might trigger irritation and redness. Will be absorbed by the pores and skin inflicting systemic poisoning; signs could parallel ingestion. Eyes
Acrylamide options could trigger eye irritation. Carcinogenicity
Acrylamide is suspected as a most cancers hazard. Might trigger most cancers. Listed by NTP as a suspected carcinogen. Acrylamide is understood to the State of California to trigger most cancers. Mutagenicity
Acrylamide was damaging within the Ames assay each with and with out metabolic activation. Reproductive Toxicity
Acrylamide induced male reproductive toxicity has been demonstrated in Lengthy-Evans rats the place given higher than or equal to 15 mg/kg/day acrylamide orally by gavage for 5 consecutive days. On this examine, males receiving higher than or equal to 15 mg/kg/day acrylamide had a lowered fertility index.